Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 54

1.

STAT3 inhibition induces Bax-dependent apoptosis in liver tumor myeloid-derived suppressor cells.

Guha P, Gardell J, Darpolor J, Cunetta M, Lima M, Miller G, Espat NJ, Junghans RP, Katz SC.

Oncogene. 2018 Aug 29. doi: 10.1038/s41388-018-0449-z. [Epub ahead of print]

PMID:
30158673
2.

Early Investigations and Recent Advances in Intraperitoneal Immunotherapy for Peritoneal Metastasis.

Thadi A, Khalili M, Morano WF, Richard SD, Katz SC, Bowne WB.

Vaccines (Basel). 2018 Aug 10;6(3). pii: E54. doi: 10.3390/vaccines6030054. Review.

3.

Glycogen synthase kinase 3 inhibition lowers PD-1 expression, promotes long-term survival and memory generation in antigen-specific CAR-T cells.

Sengupta S, Katz SC, Sengupta S, Sampath P.

Cancer Lett. 2018 Oct 1;433:131-139. doi: 10.1016/j.canlet.2018.06.035. Epub 2018 Jun 27.

PMID:
29959057
4.

Regional Infusion of Chimeric Antigen Receptor T Cells to Overcome Barriers for Solid Tumor Immunotherapy.

Hardaway JC, Prince E, Arepally A, Katz SC.

J Vasc Interv Radiol. 2018 Jul;29(7):1017-1021.e1. doi: 10.1016/j.jvir.2018.03.001. No abstract available.

PMID:
29935783
5.

Trends in Incidence and Factors Affecting Survival of Patients With Cholangiocarcinoma in the United States.

Mukkamalla SKR, Naseri HM, Kim BM, Katz SC, Armenio VA.

J Natl Compr Canc Netw. 2018 Apr;16(4):370-376. doi: 10.6004/jnccn.2017.7056.

PMID:
29632056
6.

Association of primary tumor lymph node ratio with burden of liver metastases and survival in stage IV colorectal cancer.

Ahmad A, Reha J, Saied A, Espat NJ, Somasundar P, Katz SC.

Hepatobiliary Surg Nutr. 2017 Jun;6(3):154-161. doi: 10.21037/hbsn.2016.08.08.

7.

Frontline Science: Functionally impaired geriatric CAR-T cells rescued by increased α5β1 integrin expression.

Guha P, Cunetta M, Somasundar P, Espat NJ, Junghans RP, Katz SC.

J Leukoc Biol. 2017 Aug;102(2):201-208. doi: 10.1189/jlb.5HI0716-322RR. Epub 2017 May 25.

PMID:
28546503
8.

Regional immunotherapy for liver and peritoneal metastases.

Reha J, Katz SC.

J Surg Oncol. 2017 Jul;116(1):46-54. doi: 10.1002/jso.24641. Epub 2017 May 22. Review.

PMID:
28543176
9.

Tumor-Associated Macrophage Infiltration in Colorectal Cancer Liver Metastases is Associated With Better Outcome.

Cavnar MJ, Turcotte S, Katz SC, Kuk D, Gönen M, Shia J, Allen PJ, Balachandran VP, D'Angelica MI, Kingham TP, Jarnagin WR, DeMatteo RP.

Ann Surg Oncol. 2017 Jul;24(7):1835-1842. doi: 10.1245/s10434-017-5812-8. Epub 2017 Feb 17.

10.

Predictors of surgical non-referral for colorectal liver metastases.

Ahmad A, Reha J, Somasundar P, Espat NJ, Katz SC.

J Surg Res. 2016 Sep;205(1):198-203. doi: 10.1016/j.jss.2016.06.037. Epub 2016 Jun 21.

PMID:
27621019
11.

Mincle Signaling Promotes Con A Hepatitis.

Greco SH, Torres-Hernandez A, Kalabin A, Whiteman C, Rokosh R, Ravirala S, Ochi A, Gutierrez J, Salyana MA, Mani VR, Nagaraj SV, Deutsch M, Seifert L, Daley D, Barilla R, Hundeyin M, Nikifrov Y, Tejada K, Gelb BE, Katz SC, Miller G.

J Immunol. 2016 Oct 1;197(7):2816-27. doi: 10.4049/jimmunol.1600598. Epub 2016 Aug 24.

12.

Dermatofibrosarcoma Protuberans.

Reha J, Katz SC.

Surg Clin North Am. 2016 Oct;96(5):1031-46. doi: 10.1016/j.suc.2016.05.006. Review.

PMID:
27542641
13.

Tailoring Surgical Therapy for Extremity Soft Tissue Sarcoma.

Katz SC.

Ann Surg Oncol. 2017 Jan;24(1):13-14. doi: 10.1245/s10434-016-5468-9. Epub 2016 Aug 1. No abstract available.

PMID:
27480357
14.

Gastrointestinal stromal tumour metastatic to the epididymis.

Ahmad A, Libbey NP, Somasundar P, Katz SC.

BMJ Case Rep. 2015 Sep 23;2015. pii: bcr2015211555. doi: 10.1136/bcr-2015-211555.

15.

Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor-Modified T-cell Therapy for CEA+ Liver Metastases.

Katz SC, Burga RA, McCormack E, Wang LJ, Mooring W, Point GR, Khare PD, Thorn M, Ma Q, Stainken BF, Assanah EO, Davies R, Espat NJ, Junghans RP.

Clin Cancer Res. 2015 Jul 15;21(14):3149-59. doi: 10.1158/1078-0432.CCR-14-1421. Epub 2015 Apr 7.

16.

Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T.

Burga RA, Thorn M, Point GR, Guha P, Nguyen CT, Licata LA, DeMatteo RP, Ayala A, Joseph Espat N, Junghans RP, Katz SC.

Cancer Immunol Immunother. 2015 Jul;64(7):817-29. doi: 10.1007/s00262-015-1692-6. Epub 2015 Apr 8.

17.

Chemotherapy does not adversely impact outcome following post-incisional hernia repair with biomaterial mesh.

Saied A, David J, LaBarbera K, Katz SC, Somasundar P.

J Surg Oncol. 2015 May;111(6):725-8. doi: 10.1002/jso.23869. Epub 2015 Jan 8.

PMID:
25580588
18.

Liver metastases induce reversible hepatic B cell dysfunction mediated by Gr-1+CD11b+ myeloid cells.

Thorn M, Point GR, Burga RA, Nguyen CT, Joseph Espat N, Katz SC.

J Leukoc Biol. 2014 Nov;96(5):883-94. doi: 10.1189/jlb.3A0114-012RR. Epub 2014 Aug 1.

19.

The prognostic value of liver tumor T cell infiltrates.

Khan H, Pillarisetty VG, Katz SC.

J Surg Res. 2014 Sep;191(1):189-95. doi: 10.1016/j.jss.2014.06.001. Epub 2014 Jun 7. Review.

20.

Hepatic PEComa: a potential pitfall in the evaluation of hepatic neoplasms.

Khan HM, Katz SC, Libbey NP, Somasundar PS.

BMJ Case Rep. 2014 Jun 6;2014. pii: bcr2014204122. doi: 10.1136/bcr-2014-204122.

Supplemental Content

Loading ...
Support Center